The outlook of companies tied to the drug's legacy presents a challenging investment landscape. While the initial surge generated substantial gains, generic alternatives have significantly diminished market https://whitebookmarks.com/story21708208/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-venture